Course Director：韩杰、里程楠、刘新民、王斌、王坚刚

主席

主持人

讨论嘉宾

学习目标： 1. 认知材料革命： 了解新一代抗钙化、高耐久性高分子材料及先进生物材料瓣膜的研发进展，及其对未来内外科医生临床全生命周期瓣膜规划的颠覆性影响。 2. 精通复合术式： 掌握针对复杂、多瓣膜或高危复发病例中，心内科与心外科联合开展“一站式”或“分期”复合手术（Hybrid Surgery）的方案设计原则与台下团队配合。 3. 拥抱数字化医疗： 认识人工智能（AI）在瓣膜病早期自动化筛查、术前三维精细解剖规划、及术后远程智能随访系统中的革命性应用新范式。

讨论建议： 1. 材料驱动的指南改写： 随着具有极高耐久性和抗钙化能力的新型高分子/生物材料瓣膜逐步进入临床，这是否会推动瓣膜置换患者群体的显著年轻化，进而改写现有指南中的年龄切点？ With the clinical introduction of novel polymeric or biomaterial valves boasting extreme durability and anti-calcification properties, will this accelerate a shift toward younger patient cohorts for valve replacement and rewrite the age thresholds in current guidelines? 2. 复合手术（Hybrid）的流程优化： 面对复杂多瓣膜病变或经历过多次外科开胸的手术“荒漠”患者，如何构建更高效的心内外科复合手术流程及应急保障，以最大程度降低高危患者的联合围术期风险？ For patients with complex multi-valvular disease or those who have undergone multiple prior open-heart surgeries, how can we build a more efficient hybrid workflow and emergency safety net to minimize perioperative risks? 3. AI技术的落地与赋能： AI驱动的智能化手术规划与全自动筛查在头部中心已显现优势，如何将其下沉、普及至基层医院，以建立起辐射全国的瓣膜病全生命周期远程管理网络？ While AI-driven intelligent procedural planning and automated screening have demonstrated superiority in leading medical centers, how can we propagate these technologies to primary hospitals to establish a nationwide remote management network for the lifelong care of valvular disease?

从手术即刻成功迈向主动脉瓣疾病的全生命周期管理 From Immediate Success to Lifetime Management of Aortic Valve Disease

讨论

经导管治疗单纯主动脉瓣反流解决方案的现状与突破 Current Status and Breakthroughs in Transcatheter Solutions for Aortic Regurgitation

讨论

复杂心脏瓣膜病的“心内外科复合手术”策略 Hybrid "Heart Team" Surgical Strategies for Complex Valvular Heart Disease

讨论

AI 驱动下的瓣膜病筛查、手术规划与术后远程管理新范式 AI-Driven Paradigms for Valvular Disease Screening, Procedural Planning, and Postoperative Remote Management

讨论